MedPath

VANDERBILT UNIVERSITY MEDICAL CENTER

VANDERBILT UNIVERSITY MEDICAL CENTER logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1925-01-01
Employees
10K
Market Cap
-
Website
http://www.vumc.org

Characteristics of Glargine in Type 2 Diabetics

Phase 1
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: Placebo
Drug: Insulin Glargine 0.5 u/kg body wt SC
Drug: Insulin Glargine 1.0 u/kg body wt SC
Drug: Insulin Glargine 1.5 u/kg body wt SC
Drug: Insulin Glargine 2.0 u/kg body wt SC
First Posted Date
2007-12-17
Last Posted Date
2017-04-17
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
20
Registration Number
NCT00574912
Locations
🇺🇸

Vanderbilt University, Nashville, Tennessee, United States

Physiological Brain Atlas Development

Recruiting
Conditions
Parkinson's Disease
Dystonia
Epilepsy
Essential Tremor
Obsessive Compulsive Disorder
Interventions
Device: Stereotactic brain procedures
First Posted Date
2007-12-17
Last Posted Date
2023-08-14
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
5000
Registration Number
NCT00575081
Locations
🇺🇸

Vanderbilt Univeristy, Nashville, Tennessee, United States

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

Completed
Conditions
Esophageal Cancer
Head and Neck Cancer
Lung Cancer
Neurocognitive Impairment
Delirium
Interventions
Other: Assessment of therapy complications
Other: Neurocognitive assessment
Other: Quality-of-life assessment
First Posted Date
2007-09-24
Last Posted Date
2017-04-07
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
86
Registration Number
NCT00533884
Locations
🇺🇸

MBCCOP - Meharry Medical College - Nashville, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States

and more 1 locations

Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C

Terminated
Conditions
Hyperlipidemia
First Posted Date
2007-09-05
Last Posted Date
2017-04-04
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
19
Registration Number
NCT00525083
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Elevated Serum HDL in Four Generations of a Nashville Family

Terminated
Conditions
Hyperlipidemias
Interventions
Other: No Intervention
First Posted Date
2007-09-05
Last Posted Date
2017-03-20
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
3
Registration Number
NCT00525109
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

ExploR™ Modular Radial Head Data Collection

Active, not recruiting
Conditions
Elbow Fracture
Interventions
Device: Biomet Explor Modular Radial Head Replacement
First Posted Date
2007-08-28
Last Posted Date
2024-02-13
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
50
Registration Number
NCT00521846
Locations
🇺🇸

Vanderbilt University, Nashville, Tennessee, United States

Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas

Phase 4
Completed
Conditions
Crohn Disease
Rectal Fistula
Interventions
Procedure: EUA with seton placement if necessary
Drug: adalimumab
Procedure: EUS
First Posted Date
2007-08-16
Last Posted Date
2017-04-21
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
21
Registration Number
NCT00517296
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Diurnal Variation of Plasminogen Activator Inhibitor-1

Phase 4
Completed
Conditions
Metabolic Syndrome X
Interventions
First Posted Date
2007-08-13
Last Posted Date
2019-02-01
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
21
Registration Number
NCT00515021
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm

Completed
Conditions
Aortic Aneurysm, Abdominal
First Posted Date
2007-08-09
Last Posted Date
2017-04-07
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
14
Registration Number
NCT00513773
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

Not Applicable
Completed
Conditions
Crohn's Disease
Interventions
Procedure: Fecal calprotectin
Procedure: Urinary PGE-M Level
First Posted Date
2007-07-04
Last Posted Date
2017-05-02
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
159
Registration Number
NCT00496548
Locations
🇺🇸

GI Clinical Research; Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath